Skip to main content

Table 2 Docking and binding energy of gyp LI with ten target molecules

From: Comprehensive network pharmacology and experimentation to unveil the therapeutic efficacy and mechanisms of gypenoside LI in anaplastic thyroid cancer

Component

Gene

PDB ID

ΔGb (Kcal/mol)

Gypenoside LI

HSP90AA1

3T0H

-5.84

Gypenoside LI

SRC

1FMK

-4.87

Gypenoside LI

CASP3

6X8I

-3.34

Gypenoside LI

IL2

6YIO

-2.88

Gypenoside LI

VEGFA

1FLT

-2.51

Gypenoside LI

EGFR

1XKK

-1.81

Gypenoside LI

GRB2

1GCQ

-1.55

Gypenoside LI

PI3KCA

7L1C

-1.38

Gypenoside LI

STAT3

6NJS

-0.41

Gypenoside LI

FGF2

5X10

0.39